Human CCL7/MCP‑3/MARC Biotinylated Antibody
R&D Systems, part of Bio-Techne | Catalog # BAF282
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Gln34-Leu109
Accession # Q7Z7Q8
Specificity
Clonality
Host
Isotype
Applications for Human CCL7/MCP‑3/MARC Biotinylated Antibody
Western Blot
Sample: Recombinant Human CCL7/MCP-3/MARC (Catalog # 282-P3)
Human CCL7/MCP-3 Sandwich Immunoassay
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CCL7/MCP-3/MARC
MCP-2 and CCL7 are two monocyte chemotactic proteins produced by human MG-63 osteosarcoma cells. Both MCP-2 and CCL7 are members of the C-C family of chemokines and share 62% and 71% amino acid sequence identity, respectively, with MCP-1. CCL7 also shares 58% amino acid identity with MCP-2.
CCL7 cDNA encodes a 99 amino acid residue precursor protein from which the N-terminal 23 amino acid residues are cleaved to generate the 76 amino acid residue mature CCL7. Mature CCL7 contains a potential N-linked and several possible O-linked glycosylation sites.
Similarly to other C-C chemokines, all three MCP proteins are monocyte chemoattractants. In addition, the three MCPs can chemoattract activated NK cells as well as CD4+ and CD8+ T lymphocytes. All three cytokines have also been shown to attract eosinophils and induce histamine secretion from basophils.
Alternate Names
Gene Symbol
UniProt
Additional CCL7/MCP-3/MARC Products
Product Documents for Human CCL7/MCP‑3/MARC Biotinylated Antibody
Product Specific Notices for Human CCL7/MCP‑3/MARC Biotinylated Antibody
For research use only